Association of Interleukin-6-174G/C Gene Promotor Polymorphism with Rheumatoid Arthritis in Adolescence: A Case-control StudyCorrespondence Address :
Sergei Egorovich Khalchitsky,
Parkovaya 64-68, Pushkin, Saint-Petersburg-196603, Russia, Saint-Petersburg, Russia.
Introduction: Rheumatoid Arthritis (RA) is a chronic autoimmune disease with unknown pathogenesis. The disease is multifactorial, however, the exact causes of the occurrence, as well as the targets of the autoimmune process, are unknown. Genes candidate for a predisposition to RA are cytokine genes. Of the cytokines, IL-6 is considered a key mediator of systemic and localised inflammation in RA.
Aim: The comparative analysis of the frequency distribution of alleles and genotypes IL-6-174G/C polymorphism in patients with RA and in the control group to determine the genotype most characteristic of this disease.
Materials and Methods: This case-control study was conducted in a group of 136 children with RA aged 14 to 18 years. In the control group, there were 143 practically healthy children of similar age without RA and orthopaedic pathology. Both groups were tested for polymorphism IL-6-174G/C using real-time Polymerase Chain Reaction (real-time PCR). The results were statistically processed using the Pearson's Chi-square test.
Results: The distribution of 174G/C genotypes in the IL-6 gene was significantly different in patients with RA when compared with the control group. In patients with RA, heterozygous carriers of 174G/C (52.94%) prevailed, while in the control group the most numerous group were homozygous carriers of -174G/G (40.56%).
Conclusion: As a result of this study, it was possible to identify significant differences in distribution of genotypes 174G/C polymorphism in IL-6 gene between patients with RA and subjects of the control group. In relation to the European population of the Russian Federation, this polymorphism can serve as a diagnostic marker in the study of the pathogenesis of RA.
Cytokines, C-Reactive protein, Diagnostic marker, Tumour necrosis factor
Date of Submission: Aug 23, 2020
Date of Peer Review: Nov 10, 2020
Date of Acceptance: Mar 08, 2021
Date of Publishing: Jun 01, 2021
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 09, 2020
• Manual Googling: Feb 12, 2021
• iThenticate Software: Apr 17, 2021 (17%)
Etymology: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)